Frank Meszaros, MD
Physical Medicine & Rehabilitation · Lancaster, OHNPI 1184620676
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,667 of the $3,550 with a category attached, or 75.1%. Boston Scientific accounts for 60.0% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $2,287 and has fallen 98.5% since, to $33 in 2025.
Across 127 payments — averaging $27.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Nevro Corp.$378
- Pfizer$211
- Collegium Pharmaceutical, Inc.$138
- Abbott$129
- Amgen$108
- plus $456 from 12 others
What the payments were for
- Travel & lodging$88325%
- Food & beverage$2,66775%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 41 | $2,131 |
| Nevro Corp. | 14 | $378 |
| Pfizer | 24 | $211 |
| Collegium Pharmaceutical, Inc. | 10 | $138 |
| Abbott | 5 | $129 |
| Amgen | 5 | $108 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $108 |
| Si-bone, Inc. | 4 | $74 |
| Biodelivery Sciences International, Inc. | 3 | $52 |
| Lilly USA, LLC | 3 | $37 |
| Novartis | 2 | $36 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Scilex Pharmaceuticals Inc. | 1 | $21 |
| Vertiflex, Inc. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
| Redhill Biopharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,550 in reported general payments places this provider in the 85th percentile of 332 physical medicine & rehabilitation providers in Ohio.
See all physical medicine & rehabilitation providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 28 | $31,516 |
| MovantikNaloxegol Oxalate | 17 | $9,555 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 355 | $9,133 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 276 | $6,538 |
| Pregabalin | 176 | $5,954 |
| Gabapentin | 388 | $4,231 |
| Oxycodone Hcl | 176 | $3,334 |
| Tramadol Hcl | 190 | $1,525 |
| Celecoxib | 68 | $1,514 |
| Lidocaine | 14 | $1,382 |
| Morphine Sulfate ErMorphine Sulfate | 29 | $1,364 |
| Fentanyl | 12 | $1,243 |
| Tizanidine Hcl | 88 | $964 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 17 | $835 |
| Cyclobenzaprine Hcl | 124 | $765 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $138 | $31,51628 claims |
| Redhill Biopharma Inc.Movantik | $12 | $9,55517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 332 physical medicine & rehabilitation providers in Ohio.
Other physical medicine & rehabilitation in Lancaster
- John WalterLancaster$2K
- Michael BariaLewis Center$175K
- Kathryn MosherAkron$121K
- Marc OrlandoCincinnati$114K
- Aileen PadillaPerrysburg$73K
- Jeffrey StrakowskiColumbus$59K
- Kurt KuhlmanLima$46K
- Francois BethouxCleveland$39K
- Caitlin StuberColumbus$33K
- Francesco SammartinoDublin$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.